Gilotrif ( Afatinib ) a New Cancer Drug Treats EGFR Positive Non-Small Cell Lung Cancer

Gilotrif (Afatinib) is a FDA approved lung cancer drug that targets advanced lung cancer, such as metastatic non-small cell lung cancer. Taken as a pill, this new targeted therapy treats people...